{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:07:12Z","timestamp":1774544832844,"version":"3.50.1"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["5K12HD001097-17"],"award-info":[{"award-number":["5K12HD001097-17"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HD060586"],"award-info":[{"award-number":["HD060586"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01NS079163"],"award-info":[{"award-number":["U01NS079163"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Marshal Heritage Foundation"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0167077","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T19:03:53Z","timestamp":1480619033000},"page":"e0167077","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Normalization of Patient-Identified Plasma Biomarkers in SMN\u03947 Mice following Postnatal SMN Restoration"],"prefix":"10.1371","volume":"11","author":[{"given":"W. David","family":"Arnold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Duque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chitra C.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Zaworski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicki L.","family":"McGovern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon J.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharine M.","family":"von Herrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dione T.","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen S.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey V.","family":"Paushkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur H. M.","family":"Burghes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"issue":"239","key":"ref1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/adc.45.239.33","article-title":"The genetic component in child mortality","volume":"45","author":"DF Roberts","year":"1970","journal-title":"Arch Dis Child"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/nbdi.1996.0010","article-title":"The neurobiology of childhood spinal muscular atrophy","volume":"3","author":"TO Crawford","year":"1996","journal-title":"Neurobiol Dis"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"S Lefebvre","year":"1995","journal-title":"Cell"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ng0797-265","article-title":"Correlation between severity and SMN protein level in spinal muscular atrophy","volume":"16","author":"S Lefebvre","year":"1997","journal-title":"Nat Genet"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/hmg\/6.8.1205","article-title":"The survival motor neuron protein in spinal muscular atrophy","volume":"6","author":"DD Coovert","year":"1997","journal-title":"Hum Mol Genet"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","article-title":"A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy","volume":"96","author":"CL Lorson","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"ref7","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","article-title":"A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2","volume":"8","author":"UR Monani","year":"1999","journal-title":"Hum Mol Genet"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/bbrc.1995.2135","article-title":"Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients","volume":"213","author":"M Gennarelli","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng854","article-title":"Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1","volume":"30","author":"L Cartegni","year":"2002","journal-title":"Nat Genet"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ng1207","article-title":"A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy","volume":"34","author":"T Kashima","year":"2003","journal-title":"Nat Genet"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ng0598-63","article-title":"SMN oligomerization defect correlates with spinal muscular atrophy severity","volume":"19","author":"CL Lorson","year":"1998","journal-title":"Nat Genet"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/hmg\/9.2.259","article-title":"An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN","volume":"9","author":"CL Lorson","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1128\/MCB.01262-08","article-title":"Regulation of SMN protein stability","volume":"29","author":"BG Burnett","year":"2009","journal-title":"Molecular and cellular biology"},{"issue":"5\u20136","key":"ref14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0960-8966(06)80015-5","article-title":"International SMA consortium meeting. (26\u201328 June 1992, Bonn, Germany)","volume":"2","author":"TL Munsat","year":"1992","journal-title":"Neuromuscular disorders: NMD"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archneur.1995.00540290108025","article-title":"Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications","volume":"52","author":"K Zerres","year":"1995","journal-title":"Arch Neurol"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/515465","article-title":"Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number","volume":"60","author":"PE McAndrew","year":"1997","journal-title":"Am J Hum Genet"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00125817-200201000-00004","article-title":"Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2","volume":"4","author":"MD Mailman","year":"2002","journal-title":"Genetics in medicine: official journal of the American College of Medical Genetics"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/mus.21350","article-title":"An analysis of disease severity based on SMN2 copy number in adults with spinal muscular atrophy","volume":"40","author":"B Elsheikh","year":"2009","journal-title":"Muscle & nerve"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1086\/302369","article-title":"Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling","volume":"64","author":"B Wirth","year":"1999","journal-title":"Am J Hum Genet"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/513886","article-title":"Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype","volume":"61","author":"L Campbell","year":"1997","journal-title":"Am J Hum Genet"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/338627","article-title":"Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy","volume":"70","author":"M Feldkotter","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajhg.2009.08.002","article-title":"A positive modifier of spinal muscular atrophy in the SMN2 gene","volume":"85","author":"TW Prior","year":"2009","journal-title":"Am J Hum Genet"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"E1110","DOI":"10.1002\/humu.21173","article-title":"A rare SMN2 variant in a previously unrecognized composite splicing regulatory element induces exon 7 inclusion and reduces the clinical severity of spinal muscular atrophy","volume":"31","author":"M Vezain","year":"2010","journal-title":"Human mutation"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/jmg.2010.079004","article-title":"The c.859G>C variant in the SMN2 gene is associated with types II and III SMA and originates from a common ancestor","volume":"47","author":"S Bernal","year":"2010","journal-title":"Journal of medical genetics"},{"issue":"8","key":"ref25","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrn2670","article-title":"Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?","volume":"10","author":"AH Burghes","year":"2009","journal-title":"Nature Reviews Neuroscience"},{"key":"ref26","article-title":"Spinal muscular atrophy: The development and implementation of potential treatments","author":"WD Arnold","year":"2013","journal-title":"Ann Neurol"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/hmg\/9.3.333","article-title":"The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn\u2013\/\u2013mice and results in a mouse with spinal muscular atrophy","volume":"9","author":"UR Monani","year":"2000","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/71709","article-title":"A mouse model for spinal muscular atrophy","volume":"24","author":"HM Hsieh-Li","year":"2000","journal-title":"Nat Genet"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/hmg\/ddi078","article-title":"SMN\u03947, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN","volume":"14","author":"TT Le","year":"2005","journal-title":"Human Molecular Genetics"},{"issue":"6197","key":"ref30","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.1250127","article-title":"Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy","volume":"345","author":"NA Naryshkin","year":"2014","journal-title":"Science (New York, NY)"},{"issue":"7","key":"ref31","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nchembio.1837","article-title":"SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice","volume":"11","author":"J Palacino","year":"2015","journal-title":"Nat Chem Biol"},{"issue":"72","key":"ref32","doi-asserted-by":"crossref","first-page":"72ra18","DOI":"10.1126\/scitranslmed.3001777","article-title":"Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy","volume":"3","author":"MA Passini","year":"2011","journal-title":"Science translational medicine"},{"issue":"7367","key":"ref33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nature10485","article-title":"Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model","volume":"478","author":"Y Hua","year":"2011","journal-title":"Nature"},{"issue":"7","key":"ref34","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/hmg\/ddr600","article-title":"A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse","volume":"21","author":"PN Porensky","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN","volume":"28","author":"KD Foust","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"35","key":"ref36","doi-asserted-by":"crossref","first-page":"35ra42","DOI":"10.1126\/scitranslmed.3000830","article-title":"Systemic Delivery of scAAV9 Expressing SMN Prolongs Survival in a Model of Spinal Muscular Atrophy","volume":"2","author":"CF Valori","year":"2010","journal-title":"Science Translational Medicine"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/hmg\/ddq514","article-title":"Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice","volume":"20","author":"E Dominguez","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI41615","article-title":"CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy","volume":"120","author":"MA Passini","year":"2010","journal-title":"The Journal of clinical investigation"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.24497","article-title":"Spinal muscular atrophy: diagnosis and management in a new therapeutic era","volume":"51","author":"WD Arnold","year":"2015","journal-title":"Muscle & nerve"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ana.24332","article-title":"A large animal model of spinal muscular atrophy and correction of phenotype","volume":"77","author":"SI Duque","year":"2015","journal-title":"Ann Neurol"},{"issue":"10","key":"ref41","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","article-title":"Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy","volume":"86","author":"CA Chiriboga","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/ijms12010024","article-title":"Biomarkers in rare disorders: the experience with spinal muscular atrophy","volume":"12","author":"FD Tiziano","year":"2010","journal-title":"International journal of molecular sciences"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/acn3.283","article-title":"Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study","volume":"3","author":"SJ Kolb","year":"2016","journal-title":"Annals of clinical and translational neurology"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.20473","article-title":"Natural history of denervation in SMA: Relation to age, SMN2 copy number, and function","volume":"57","author":"KJ Swoboda","year":"2005","journal-title":"Annals of Neurology"},{"issue":"1\u20132","key":"ref45","first-page":"178","article-title":"Quantitative muscle ultrasound measures rapid declines over time in children with SMA type 1","volume":"358","author":"KW Ng","year":"2015","journal-title":"Journal of the neurological sciences"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.pediatrneurol.2014.02.015","article-title":"Cross-sectional evaluation of electrical impedance myography and quantitative ultrasound for the assessment of Duchenne muscular dystrophy in a clinical trial setting","volume":"51","author":"SB Rutkove","year":"2014","journal-title":"Pediatric neurology"},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/mus.21838","article-title":"Compound muscle action potential and motor function in children with spinal muscular atrophy","volume":"42","author":"A Lewelt","year":"2010","journal-title":"Muscle & nerve"},{"issue":"3","key":"ref48","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/mus.10050","article-title":"Motor unit number estimation in infants and children with spinal muscular atrophy","volume":"25","author":"MB Bromberg","year":"2002","journal-title":"Muscle & nerve"},{"issue":"6","key":"ref49","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/archneurol.2010.373","article-title":"Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year","volume":"68","author":"P Kaufmann","year":"2011","journal-title":"Arch Neurol"},{"issue":"18","key":"ref50","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1212\/WNL.0b013e318271f7e4","article-title":"Prospective cohort study of spinal muscular atrophy types 2 and 3","volume":"79","author":"P Kaufmann","year":"2012","journal-title":"Neurology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.nbd.2015.12.014","article-title":"The neuromuscular impact of symptomatic SMN restoration in a mouse model of spinal muscular atrophy","volume":"87","author":"W Arnold","year":"2016","journal-title":"Neurobiol Dis"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/acn3.23","article-title":"Electrophysiological Biomarkers in Spinal Muscular Atrophy: Preclinical Proof of Concept","volume":"1","author":"WD Arnold","year":"2014","journal-title":"Annals of clinical and translational neurology"},{"issue":"43","key":"ref53","doi-asserted-by":"crossref","first-page":"E5863","DOI":"10.1073\/pnas.1509758112","article-title":"Systemic, postsymptomatic antisense oligonucleotide rescues motor unit maturation delay in a new mouse model for type II\/III spinal muscular atrophy","volume":"112","author":"LP Bogdanik","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref54","doi-asserted-by":"crossref","first-page":"e35462","DOI":"10.1371\/journal.pone.0035462","article-title":"Candidate proteins, metabolites and transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) clinical study","volume":"7","author":"RS Finkel","year":"2012","journal-title":"PLoS ONE"},{"issue":"4","key":"ref55","doi-asserted-by":"crossref","first-page":"e60113","DOI":"10.1371\/journal.pone.0060113","article-title":"SMA-MAP: a plasma protein panel for spinal muscular atrophy","volume":"8","author":"DT Kobayashi","year":"2013","journal-title":"PloS one"},{"key":"ref56","article-title":"SMN expression is required in motor neurons to rescue electrophysiological deficits in the SMNDelta7 mouse model of SMA","author":"VL McGovern","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"103","key":"ref57","doi-asserted-by":"crossref","DOI":"10.3791\/52899","article-title":"Electrophysiological Motor Unit Number Estimation (MUNE) Measuring Compound Muscle Action Potential (CMAP) in Mouse Hindlimb Muscles","author":"WD Arnold","year":"2015","journal-title":"Journal of visualized experiments: JoVE"},{"issue":"3","key":"ref58","doi-asserted-by":"crossref","first-page":"e0150640","DOI":"10.1371\/journal.pone.0150640","article-title":"SMN Protein Can Be Reliably Measured in Whole Blood with an Electrochemiluminescence (ECL) Immunoassay: Implications for Clinical Trials","volume":"11","author":"P Zaworski","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"ref59","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/acn3.23","article-title":"Electrophysiological Biomarkers in Spinal Muscular Atrophy: Preclinical Proof of Concept","volume":"1","author":"WD Arnold","year":"2014","journal-title":"Annals of clinical and translational neurology"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"17632","DOI":"10.1038\/srep17632","article-title":"Tetranectin as a Potential Biomarker for Stable Coronary Artery Disease","volume":"5","author":"Y Chen","year":"2015","journal-title":"Scientific reports"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3389\/fimmu.2015.00386","article-title":"DPP4 in Diabetes","volume":"6","author":"D Rohrborn","year":"2015","journal-title":"Frontiers in immunology"},{"issue":"2","key":"ref62","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ana.23582","article-title":"Glucose metabolism and pancreatic defects in spinal muscular atrophy","volume":"72","author":"M Bowerman","year":"2012","journal-title":"Annals of neurology"},{"issue":"11","key":"ref63","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1177\/1352458513477923","article-title":"Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis","volume":"19","author":"VK Harris","year":"2013","journal-title":"Multiple sclerosis (Houndmills, Basingstoke, England)"},{"issue":"12","key":"ref64","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/rheumatology\/ken385","article-title":"Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis","volume":"47","author":"ST Choi","year":"2008","journal-title":"Rheumatology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0167077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T07:08:21Z","timestamp":1589008101000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0167077"}},"subtitle":[],"editor":[{"given":"Ferdinando","family":"Di Cunto","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,12,1]]},"references-count":64,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0167077","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,1]]}}}